Difference between revisions of "Aripiprazole LA-Amisulpride"
From Psychiatrienet
(Created page with '{{Drugswitch | from = Aripiprazole LA | to = Amisulpride | stop = {{Lastinjection}} | start = {{Startslweeks}} | info = {{caveQT}} | view = StopDepotStartOral.jpg') |
(No difference)
|
Revision as of 16:45, 16 March 2015
{{Drugswitch | from = Aripiprazole LA | to = Amisulpride | stop =
- Day 1: Last depot injection
| start =
- Week 1-3: approx. 25% of target dose
- Week 4-6: approx. 50% of target dose
- Week 7-9: approx. 75% of target dose
- Week 10: target dose
| info =
- During this switch you could monitor ECG, especially in patients prone to QT-conduction problems.
- There is a possibility of QT interval prolongation.[1]
| view = StopDepotStartOral.jpg
- ↑ Stöllberger C, Huber JO, Finsterer J, Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005 Sep;20(5):243-51.
